La vacuna frente a papilomavirus Cecolin 9 como alternativa en países de renta económica media-baja
Zhu F, Zhong G, Huang W et al. Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial. Lancet Infect Dis Published online July 17, 2023 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00275-X/fulltext En el año 2021 la OMS precualificó la vacuna Cecolin (producida…
